12:00 AM
 | 
Oct 29, 2012
 |  BC Week In Review  |  Company News  |  Deals

MicuRx deal

MicuRx and Shanghai Zhangjiang Biomedical Industry Venture Capital launched Shanghai MengKe Pharmaceuticals Inc., a JV to develop and commercialize MicuRx's antibiotic MRX-I in China. Zhangjiang Biomedical will contribute RMB60 million ($9.6...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >